Figure 2. Kinetics of total anti-SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) serum antibodies in a cohort of healthcare workers who underwent voluntary administration of two doses of Pfizer-BioNTech COVID-19 mRNA-based vaccine, stratified by age and sex.